The Express-News has an exclusive look at the new uniforms by fashion designer Lee Evans Lee, founder of luxury day-wear ...

Globally, assets in ­actively managed ETFs have jumped past US $1.73 trillion by the end of September, while year-to-date ...

Hyperliquid will activate its HIP-3 network upgrade on Monday, allowing anyone who meets onchain requirements to launch perpetual futures markets on the platform. An ...

The hype surrounding artificial intelligence is more than just superficial excitement—it is reorganizing how journalism operates, from newsroom priorities to public perceptions of the news, according ...

Welcome to The Full Nerd newsletter—your weekly dose of hardware talk from the enthusiasts at PCWorld. Missed the shocking topics on our YouTube show or freshest news from across the web? You’re in ...

Opendoor Technologies OPEN-2.01%decrease; red down pointing triangle is the digital home-flipping outfit that somehow keeps clinging to life. Investors have rewarded its resilience by turning it into ...

When SEVENTEEN’s S.Coups and Mingyu announced ‘Hype Vibes’, their first joint release outside of the boyband’s main catalogue, it seemed obvious what path the record would take. The pair make up half ...

A year on, they've picked up the pieces. Under a new coach in Phil Simmons, who took charge three days after that India tour, they're trying to unlearn old habits, and build new ones. While there's ...

While Tesla has struggled to deliver on the hype of its self-driving promises, Einride has been quietly developing a Level 4 self-driving electric truck. Now, that quiet effort is paying off. For the ...

HYPE tokens closed at nearly $60 in an all-time high after 8% daily gains, while Binance-backed rival ASTER surged 350%. The native token for the decentralized crypto derivatives exchange Hyperliquid ...

Donald Trump seemed to have something else on his mind when a reporter asked him how he was “holding up” after the shooting death of his friend Charlie Kirk. The president was asked about how his ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...